AI-Driven Technologies Poised to Improve Subject Recruitment in Oncology Clinical Studies

Doctor using AI for patient recruitment
By The Editors at Uncommon Conversations,

Advancements of artificial intelligence into pharma research present opportunities for more efficient recruitment and enrollment processes for clinical trial stakeholders, while at the same time giving patients and caregivers greater access to research treatment options. Worldwide Clinical Trials, in its new partnership with Deep Lens, is pioneering efforts in AI-driven patient recruitment in oncology research. 

Read More

Artificial Intelligence Technologies Support Clinical Operations in Oncology Studies

artificial intelligence for oncology trials
By The Editors at Uncommon Conversations,

  As the pharmaceutical and medical care industries move toward adoption of artificial intelligence technologies, new possibilities are arising for improvements in drug trials through streamlined clinical operations processes. Worldwide Clinical Trials’ recent partnership with Deep Lens could provide evidence of how future drug studies can benefit from AI-driven technologies.

Read More